Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2017) 66(3) (666–668) (S0168827816307127) (10.1016/j.jhep.2016.12.007))

Wei Tien Tai, Ann Lii Cheng, Chung Wai Shiau, Hsiang Po Huang, Jui Wen Huang, Pei Jer Chen*, Kuen Feng Chen

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

Unfortunately, when correcting the figures on behalf of the authors, a mistake was introduced in Fig. 4 E by the editorial office. The correct version of Fig. 4 can be found below. The editorial office would like to apologise for this error and for any inconvenience it may have caused.

Original languageEnglish
Pages (from-to)1334-1335
Number of pages2
JournalJournal of Hepatology
Volume66
Issue number6
DOIs
StatePublished - Jun 2017

Fingerprint

Dive into the research topics of 'Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2017) 66(3) (666–668) (S0168827816307127) (10.1016/j.jhep.2016.12.007))'. Together they form a unique fingerprint.

Cite this